Journals / Kafkas Üniversitesi Veteriner Fakültesi Dergisi / 2016 / Cilt: 22 - Sayı: 3

Karbon Tetraklorüre Bağlı Ratların Karaciğerinde Oluşan Histopatolojik Değişikliklere Karşı Kefirin Koruyucu Etkisi

The Protective Effect of Kefir on Carbon Tetrachloride-induced Histopathological Changes in the Livers of Rats

Pages
403–408
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These findings indicate that kefir may have a protective role at liver damage.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of the study was to investigate the protective effects of kefir in the liver damage of rats, at experimental carbon tetrachloride (CCI4) intoxication by histologically and immunohistochemically.
📊
Key Findings & Data:During the 45 days trial period, 18, female, Wistar albino rats were used.
💡
Conclusion & Impact:These findings indicate that kefir may have a protective role at liver damage.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The aim of the study was to investigate the protective effects of kefir in the liver damage of rats, at experimental carbon tetrachloride (CCI4) intoxication by histologically and immunohistochemically. During the 45 days trial period, 18, female, Wistar albino rats were used. One of them was control, three experimental group was created. Twice a week 0.5 cc carbon tetrachloride (CCI4) + olive-oil (1:1) suspension was injected subcutaneously to the second and third group. At third group additionally to this administration 30 ml kefir was given daily by oral gavage. CCI4-induced hepatocellular damage and apoptosis was observed but these adverse findings reduced with kefir administration. These findings indicate that kefir may have a protective role at liver damage.

Özet

Çalışmada deneysel karbon tetraklorür (CCI4) toksikasyonu oluşturulan ratlarda kefirin karaciğer hasarına karşı koruyucu etkilerinin histolojik ve immunohistokimyasal olarak araştırılması amaçlandı. Kırkbeş günlük deneme boyunca, 18 adet, dişi, Wistar albino rat kullanıldı. Biri kontrol olmak üzere, üç deneme grubu oluşturuldu. Grup 2 ve 3'e haftada 2 kez 0.5 cc karbon tetraklorür (CCI4) + zeytinyağı (1:1) süspansiyonu subkutan yolla verildi. Grup 3'e buna ek olarak günlük 30 ml kefir oral gavaj yoluyla verildi. CCI4'e bağlı hepatoselüler dejenerasyon ve apoptosis gözlendi, ancak kefir eklenmesi ile bu olumsuz değişiklikler azaldı. Bu bulgular kefirin karaciğer hasarında koruyucu rolü olabileceğini gösterdi.

🔖

Cite This Article

ÖZSOY, Ş. Y. (2016). Karbon Tetraklorüre Bağlı Ratların Karaciğerinde Oluşan Histopatolojik Değişikliklere Karşı Kefirin Koruyucu Etkisi. Kafkas Üniversitesi Veteriner Fakültesi Dergisi, Cilt: 22 - Sayı: 3, 403–408. https://ajindex.com/articles/272453

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Sanlı Y: Veteriner Farmakoloji. Ankara Üniv. Vet. Fak. Yay, No: 412, Ankara, 1988. Vural N: Toksikoloji. Ankara Üniv. Eczacılık Fak. Yay, No: 56, Ankara, 1984.
  2. Özsoy N, Okyar A, Arda-Pirinçci P, Can A, Bolkent Ş, Akev N: Evaluation of Smilax excelsa L. Use in Experimentally Induced Nephrotoxicity. Kafkas Univ Vet Fak Derg, 19, 807-814, 2013. DOI: 10.9775/ kvfd.2013.9253 FAO/WHO: Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria; FAO/WHO: Amerian Córdoba Park Hotel, Córdoba, Argentina, 1-34, 2001. Fuller R: Probiotics in man and animals. J Appl Bacteriol, 66, 365-378, DOI: 10.1111/j.1365-2672.1989.tb05105.x Robert P, Fedor RN, Madsen KL: Probiotics and nutraceuticals: Non- medicinal treatments of gastrointestinal diseases. Curr Opinion Pharma,, 596-603, 2005. DOI: 10.1016/j.coph.2005.06.009 Falagas ME, Betsi GI, Athanasiou S: Probiotics for prevention of recurrent vulvovaginal candidiasis - A review. J Antimicrob Chemother, 58, 272, 2006. DOI: 10.1093/jac/dkl246 Szymanski H, Pejcz J, Jawien M, Chmielarczyk A, Strus M, Heczko PB: Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains - A randomized, double- blind, placebo-controlled trial. Aliment Pharmacol Ther, 23, 247-253, 2006. DOI: 10.1111/j.1365-2036.2006.02740.x Korolev NS: Starters for fermented milks. Sections 4, Kefir and Kumys Starters. Bulletin of the IDF 227, Chapter 2. International dairy Federation, Brussels, Belgium, 1988.
  3. Zubillaga M, Weill R, Postaire E, Goldman C, Caro R, Boccio J: Effect of probiotics and functional foods and their use in different diseases. Nutr Res, 21, 569-579, 2001. DOI: 10.1016/S0271-5317(01)00281-0
  4. Kubo M, Odani T, Nakamura S, Tokumaru S Matsuda H: Pharmacogical study on kefir a fermented milk product in Caucausus I. On antitumor activity. Yakugaku Zasshi, 112, 489-495, 1992.
  5. Duitschaever CL, Kemp N, Emmons D: Pure culture formulation and procedure for the production of kefir. Milchwissenschaft, 42, 80-82, 1987. Neve H: Analysis of kefir grain starter cultures by scanning electron microscopy. Milchwissenschaft, 47, 275-278, 1992. Hoolihan LK: Prophylactic and therapeutic use of probiotics: A review. J Am Diet Assoc, 101, 220-238, 2001. DOI: 10.1016/S0002-8223(01)00060-8 Fur